Skip to content

Clinical trials

Withdrawn Phase 1 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Status: Withdrawn Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20071
20083
20092
20101
20112
20122
20131
20145
20153
20162
20173
20183
20207
20217
20224
20238
20244
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn69

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center5
National Cancer Institute (NCI)4
City of Hope Medical Center2
Dana-Farber Cancer Institute2
Duke University2
Memorial Sloan Kettering Cancer Center2
Milton S. Hershey Medical Center2
Northwestern University2
Pfizer2
University of Alabama at Birmingham2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms69
Ovarian Neoplasms9
Lung Neoplasms7
Pancreatic Neoplasms7
Triple Negative Breast Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Neoplasm Metastasis5
Prostatic Neoplasms4
Stomach Neoplasms4
Brain Neoplasms3

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.